Financier | Commitments |
---|---|
UK: British Department for International Development (DFID) | 8.30 |
Borrower/Recipient | 7.00 |
IDA Credit | 20.00 |
P088797
Closed
Karima Saleh
N/A
November 1, 2004
(as of board presentation)
November 15, 2005
March 15, 2006
US$ 35.30 million
N/A
2006
US$ 28.30 million
B
Not Applicable
June 30, 2011
BANK APPROVED
January 15, 2013
Financier | Commitments |
---|---|
UK: British Department for International Development (DFID) | 8.30 |
Borrower/Recipient | 7.00 |
IDA Credit | 20.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 20.00 |
IBRD + IDA Commitment | 20.00 |
Lending Instrument | |
---|---|
Grant Amount | 8.30 |
Total Project Cost** | 35.30 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Sep 1, 2013 | IDA-41250 | Int Charges | 57,167.23 |
Sep 1, 2013 | IDA-41250 | Int Charges | 57,167.23 |
Mar 27, 2014 | IDA-41250 | Int Charges | 59,779.69 |
Mar 27, 2014 | IDA-41250 | Int Charges | 59,779.69 |
Mar 27, 2014 | IDA-41250 | Int Charges | 517.76 |
Mar 27, 2014 | IDA-41250 | Int Charges | 517.76 |
Sep 1, 2015 | IDA-41250 | Int Charges | 1,990.83 |
Sep 1, 2015 | IDA-41250 | Int Charges | 1,990.83 |
Mar 5, 2015 | IDA-41250 | Int Charges | 53,082.59 |
Mar 5, 2015 | IDA-41250 | Int Charges | 53,082.59 |
Mar 1, 2015 | IDA-41250 | Int Charges | 1,168.09 |
Mar 1, 2015 | IDA-41250 | Int Charges | 1,168.09 |
Sep 1, 2014 | IDA-41250 | Int Charges | 197.77 |
Sep 1, 2014 | IDA-41250 | Int Charges | 197.77 |
Sep 1, 2014 | IDA-41250 | Int Charges | 58,942.15 |
Sep 1, 2014 | IDA-41250 | Int Charges | 58,942.15 |
Sep 1, 2016 | IDA-41250 | Int Charges | 53,627.25 |
Sep 1, 2016 | IDA-41250 | Int Charges | 53,627.25 |
Sep 1, 2016 | IDA-41250 | Loan Repay | 143,936.56 |
Apr 4, 2023 | IDA-41250 | Int Charges | 42,856.21 |
Apr 4, 2023 | IDA-41250 | Int Charges | 42,856.21 |
Apr 4, 2023 | IDA-41250 | Int Charges | 37.09 |
Apr 4, 2023 | IDA-41250 | Int Charges | 37.09 |
Apr 4, 2023 | IDA-41250 | Loan Repay | 118,202.90 |
Mar 1, 2023 | IDA-41250 | Loan Repay | 16,683.53 |
Mar 1, 2023 | IDA-41250 | Loan Repay | 4,451.64 |
Sep 14, 2022 | IDA-41250 | Int Charges | 47.52 |
Sep 14, 2022 | IDA-41250 | Int Charges | 43,816.93 |
Sep 14, 2022 | IDA-41250 | Int Charges | 43,816.93 |
Sep 14, 2022 | IDA-41250 | Loan Repay | 131,784.98 |
Sep 14, 2022 | IDA-41250 | Int Charges | 47.52 |
Mar 1, 2022 | IDA-41250 | Loan Repay | 118.57 |
Mar 18, 2022 | IDA-41250 | Loan Repay | 142,863.23 |
Mar 18, 2022 | IDA-41250 | Int Charges | 44.17 |
Mar 18, 2022 | IDA-41250 | Int Charges | 44.17 |
Mar 18, 2022 | IDA-41250 | Int Charges | 47,183.61 |
Mar 18, 2022 | IDA-41250 | Int Charges | 47,183.61 |
Sep 16, 2021 | IDA-41250 | Loan Repay | 145,634.05 |
Sep 16, 2021 | IDA-41250 | Int Charges | 42.96 |
Sep 16, 2021 | IDA-41250 | Int Charges | 42.96 |
Sep 16, 2021 | IDA-41250 | Int Charges | 49,165.67 |
Sep 16, 2021 | IDA-41250 | Int Charges | 49,165.67 |
Sep 1, 2021 | IDA-41250 | Loan Repay | 1,679.01 |
Mar 15, 2021 | IDA-41250 | Int Charges | 43.13 |
Mar 15, 2021 | IDA-41250 | Int Charges | 49,907.12 |
Mar 15, 2021 | IDA-41250 | Int Charges | 49,907.12 |
Mar 15, 2021 | IDA-41250 | Int Charges | 5,606.33 |
Mar 15, 2021 | IDA-41250 | Int Charges | 5,606.33 |
Sep 15, 2020 | IDA-41250 | Int Charges | 44,483.54 |
Mar 15, 2021 | IDA-41250 | Loan Repay | 147,872.89 |
Mar 15, 2021 | IDA-41250 | Int Charges | 43.13 |
Sep 15, 2020 | IDA-41250 | Int Charges | 2,333.12 |
Sep 15, 2020 | IDA-41250 | Int Charges | 2,333.12 |
Sep 15, 2020 | IDA-41250 | Loan Repay | 146,647.23 |
Sep 15, 2020 | IDA-41250 | Int Charges | 23.97 |
Sep 15, 2020 | IDA-41250 | Int Charges | 23.97 |
Sep 15, 2020 | IDA-41250 | Int Charges | 44,483.54 |
Nov 15, 2005 | IDA-41250 | Loan Commitment | 20,000,000.00 |
Mar 1, 2024 | IDA-41250 | Loan Repay | 1,072.21 |
Apr 10, 2024 | IDA-41250 | Int Charges | 43,282.33 |
Apr 10, 2024 | IDA-41250 | Int Charges | 43,282.33 |
Apr 10, 2024 | IDA-41250 | Loan Repay | 136,331.38 |
Apr 10, 2024 | IDA-41250 | Int Charges | 28.63 |
Apr 10, 2024 | IDA-41250 | Int Charges | 28.63 |
Sep 11, 2023 | IDA-41250 | Int Charges | 79.71 |
Sep 11, 2023 | IDA-41250 | Int Charges | 79.71 |
Sep 11, 2023 | IDA-41250 | Int Charges | 43,631.23 |
Sep 11, 2023 | IDA-41250 | Int Charges | 43,631.23 |
Sep 11, 2023 | IDA-41250 | Int Charges | 2,112.26 |
Sep 11, 2023 | IDA-41250 | Int Charges | 2,112.26 |
Sep 11, 2023 | IDA-41250 | Loan Repay | 136,882.42 |
Sep 19, 2018 | IDA-41250 | Int Charges | 3,705.93 |
Sep 19, 2018 | IDA-41250 | Int Charges | 3,705.93 |
Sep 19, 2018 | IDA-41250 | Loan Repay | 145,154.52 |
Sep 19, 2018 | IDA-41250 | Int Charges | 60.48 |
Sep 19, 2018 | IDA-41250 | Int Charges | 60.48 |
Sep 19, 2018 | IDA-41250 | Int Charges | 51,711.29 |
Sep 19, 2018 | IDA-41250 | Int Charges | 51,711.29 |
Mar 9, 2020 | IDA-41250 | Int Charges | 47,685.09 |
Mar 9, 2020 | IDA-41250 | Loan Repay | 142,137.48 |
Mar 9, 2020 | IDA-41250 | Int Charges | 33.20 |
Mar 9, 2020 | IDA-41250 | Int Charges | 33.20 |
Mar 1, 2020 | IDA-41250 | Loan Repay | 2,710.13 |
Mar 9, 2020 | IDA-41250 | Int Charges | 47,685.09 |
Sep 12, 2019 | IDA-41250 | Int Charges | 445.71 |
Sep 12, 2019 | IDA-41250 | Int Charges | 445.71 |
Sep 12, 2019 | IDA-41250 | Loan Repay | 141,687.70 |
Sep 12, 2019 | IDA-41250 | Int Charges | 55.83 |
Sep 12, 2019 | IDA-41250 | Int Charges | 55.83 |
Sep 12, 2019 | IDA-41250 | Int Charges | 49,413.56 |
Sep 12, 2019 | IDA-41250 | Int Charges | 49,413.56 |
Sep 1, 2022 | IDA-41250 | Loan Repay | 2,528.60 |
Mar 1, 2016 | IDA-41250 | Int Charges | 74.21 |
Mar 1, 2016 | IDA-41250 | Int Charges | 74.21 |
Mar 1, 2016 | IDA-41250 | Loan Repay | 143,073.81 |
Mar 1, 2016 | IDA-41250 | Int Charges | 53,652.65 |
Mar 1, 2016 | IDA-41250 | Int Charges | 53,652.65 |
Sep 10, 2015 | IDA-41250 | Int Charges | 52,439.77 |
Sep 10, 2015 | IDA-41250 | Int Charges | 52,439.77 |
Mar 21, 2018 | IDA-41250 | Loan Repay | 150,178.23 |
Mar 21, 2018 | IDA-41250 | Int Charges | 43.80 |
Mar 21, 2018 | IDA-41250 | Int Charges | 43.80 |
Mar 21, 2018 | IDA-41250 | Int Charges | 50,229.98 |
Mar 21, 2018 | IDA-41250 | Int Charges | 50,229.98 |
Mar 21, 2018 | IDA-41250 | Int Charges | 4,671.66 |
Mar 21, 2018 | IDA-41250 | Int Charges | 4,671.66 |
Sep 15, 2017 | IDA-41250 | Int Charges | 49,028.03 |
Sep 15, 2017 | IDA-41250 | Int Charges | 330.91 |
Sep 15, 2017 | IDA-41250 | Int Charges | 330.91 |
Sep 15, 2017 | IDA-41250 | Loan Repay | 147,389.47 |
Sep 15, 2017 | IDA-41250 | Int Charges | 24.55 |
Sep 15, 2017 | IDA-41250 | Int Charges | 24.55 |
Sep 15, 2017 | IDA-41250 | Int Charges | 49,028.03 |
Mar 9, 2017 | IDA-41250 | Loan Repay | 139,314.12 |
Mar 9, 2017 | IDA-41250 | Int Charges | 50,913.15 |
Mar 9, 2017 | IDA-41250 | Int Charges | 50,913.15 |
Mar 1, 2017 | IDA-41250 | Loan Repay | 76.65 |
Sep 1, 2016 | IDA-41250 | Loan Repay | 514.03 |
Mar 20, 2019 | IDA-41250 | Int Charges | 50,414.15 |
Mar 20, 2019 | IDA-41250 | Int Charges | 50,414.15 |
Mar 20, 2019 | IDA-41250 | Int Charges | 54.12 |
Mar 20, 2019 | IDA-41250 | Int Charges | 54.12 |
Mar 20, 2019 | IDA-41250 | Loan Repay | 143,684.52 |
Mar 1, 2019 | IDA-41250 | Loan Repay | 622.40 |
Sep 1, 2013 | IDA-41250 | Int Charges | 1,146.82 |
Sep 1, 2013 | IDA-41250 | Int Charges | 1,146.82 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Moderately Unsatisfactory | 2011-06-27 |
Procurement | Moderately Satisfactory | 2011-06-27 |
Counterpart Funding | Moderately Satisfactory | 2011-06-27 |
Project Management | Moderately Unsatisfactory | 2011-06-27 |
Monitoring and Evaluation | Unsatisfactory | 2011-06-27 |
Overall Implementation Progress (IP) | Unsatisfactory | 2011-06-27 |
Financial Management | Satisfactory | 2011-06-27 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 12-22-2011 |
---|---|
Outcomes | Unsatisfactory |
Risk to Development Outcome | High |
Bank Performance | Moderately Unsatisfactory |
Borrower Performance | Moderately Unsatisfactory |
Government Performance | Moderately Unsatisfactory |
Implementing Agency | Moderately Unsatisfactory |
INDICATOR | ICR REVIEW: 01-09-2013 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Highly Unsatisfactory | N/a |
Risk To Development Outcome | High | N/a |
Bank Performance | Unsatisfactory | N/a |
Borrower Performance | Unsatisfactory | N/a |
Government Performance | Moderately Unsatisfactory | N/a |
Implementing Agency | Unsatisfactory | N/a |
Icr Quality | Satisfactory | N/a |
M&e Quality | Negligible | N/a |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
% of infants born to HIV-infected mothers who are infected. | Value | 30% | 5.2% | 15% |
Date | December 1, 2004 | February 24, 2011 | June 30, 2011 | |
Comment | Source: Programmatic data from the National AIDS Control Program (NACP), MOH, 2010. Sentinel site (hospital) survey found that424infants of HIV/AIDS positive mothers were tested, and 22 infants aged 18 months (born in 2007-8) were HIV/AIDS positive. |
Median age at first sex | Value | F-18.3 yrs M-20.2 yrs | F=18.4 years, M=20.1 years | F-19 yrs M-20.5 yrs |
Date | December 1, 2003 | February 24, 2011 | June 30, 2011 | |
Comment | Source: GDHS, 2008Additional data will not be collected. Such information does not change frequently. |
% of women and men who have had higher risk sex in the past 12 months. | Value | F-50%, M-83% (youth, 15-24);F=21%, M=38% (adults, | F=52.3%, M=86.4% (youth, 15-24);F=16%, M=26% (adu | F-38%, M-26% (youth, 15-49 -- 25% reduction from b |
Date | December 1, 2004 | February 24, 2011 | June 30, 2011 | |
Comment | Source: GDHS, 2008Baseline and target data were provided for youth instead of adults. GAC has asked that the baseline be givenforadults to reflect adults and not youth, as the indicator was not clearly defined in the PAD and credit agreement. |
% of men and women aged 15-49 reporting the use of a condom during higher risk sex. | Value | Adults: F-33%, M-52% Youth: F-32%, M-52% | Adults=25.4 (F), 44.7 (M)Youth= 28.2 (F), 464. (M | Adults: F-42%, M-65% Youth: F-40%, M-65% (25% incr |
Date | December 1, 2003 | February 24, 2011 | June 30, 2011 | |
Comment | Source: GDHS, 2008Requires household survey, and no additional survey is planned until next GDHS, 2013 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Ratio of current school attendance among orphans to that among non-orphans, aged 10-14. | Value | 0.80 | 0.8 | 0.90 |
Date | December 1, 2003 | February 24, 2011 | June 30, 2011 | |
Comment | Source: GDHS, 2008Wording for this indicator is defined in GDHS as:"Ratio of school attendance of children (10-14 years) whoseparents are dead to those whose parents are living, and the child resides with at least one parent" Requires household survey, andnoadditional survey is planned until next GDHS, 2013 |
% of people with advanced HIV infection receiving antiretroviral combination therapy. | Value | 3.2% | 38.6% (adults), 20.9% (children) | 66% |
Date | September 30, 2005 | February 24, 2011 | June 30, 2011 | |
Comment | Source: Programmatic data from National AIDS Control Program (NACP), MOH (2010). Data is as of June 2009.Not likely to meettargetof 66% by June 2011. |
% of total national HIV/AIDS funds spent on prevention activities for selected vulnerable groups (commercial sex workers, men having sex with men, and prisoners). | Value | 0.4% | 0.9% | 10% |
Date | December 31, 2003 | February 24, 2011 | June 30, 2011 | |
Comment | Source: National AIDS Spending Assessment (NASA) Study, 2010Spending on prevention was 17% (2009). Spending on MARPs was <1%(2009). Spending on prevention for MARPS was 5%. |
Execution rate of total HIV/AIDS allocation of the key ministries, departments and agencies (MOE, MOMP, MOLG, Dept. of Social Welfare, MOWAC). | Value | 70% | ?? | 90% |
Date | September 30, 2005 | February 24, 2011 | June 30, 2011 | |
Comment | 2009 data not yet available -- pending update from GAC. It is likely not to be available at project closing or at ICR. |
Pregnant women living with HIV who received antiretrovirals to reduce the risk of MTCT | Value | 0.00 | 36.00 | 0.00 |
Date | December 31, 2003 | November 2, 2009 | June 30, 2011 | |
Comment | PAD P22 #20 mentioned explicitly this indicator. However, no values are available at the time of retrofitting. | PAD P22 #20 mentioned explicitly this indicator. However, no values are available at the time of retrofitting. Note: % of HIVpositive pregnant women who receive a complete course of ART to prevent mother to child transmission in the last 12 months Source: NACP, MOH, 2008 | PAD P22 #20 mentioned explicitly this indicator. However, no values are available at the time of retrofitting. |